Overview of Next Generation Sequencing in Oncology Diagnostics

Thursday October 17th, 2024 | 8:15am PDT, 10:15am CDT, 11:15am EDT

In this first webinar, we will cover various applications for NGS and different aspects of comprehensive genomic tests, including variants, CNVs, rearrangements, MSI, mutational signatures, TMB, and more. Additionally, we will briefly touch on different types of tests such as ctDNA and MRD to provide a sense of the testing landscape.

Learning Objectives:

1. Understand the various use cases for next generation sequencing (NGS) in the clinical oncology diagnostics space

• Recognize the various approaches for detecting somatic mutations and why comprehensive genomic profiling is beneficial for patient outcomes

• Understand the scope of NGS comprehensive oncology panels, the different types of biomarkers they are capable of detecting, and their utility

• Identify the benefits of sequencing both DNA and RNA from the same patient sample

• Know how relevant mutational signatures may be included in a comprehensive genomic panel, how they are determined and their actionability